Earnings Call · Q3 FY2024·2024-11-05

Q3 24EPS +3.85%·Rev n/aQ2 24EPS 0.00%·Rev n/aQ1 24EPS +9.68%·Rev n/aQ4 23EPS -11.11%·Rev n/a⚠ consensus missing

TREACE MEDICAL CONCEPTS, INC. TMCI

Vivian Cervantes — Investor Relations

John Treace — Chief Executive Officer

Mark Hair — Chief Financial Officer

+6.1%1d on move date+4.9% vs SPY3d+45.5%5d+52.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TMCI calls or request research access.

More TMCI calls Browse calls Request research access